These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2672756)

  • 21. [Comparative study of thallium-201 myocardial kinetics during dipyridamole loading and exercise stress in coronary artery disease].
    Tsuda T; Kodera K; Yamamoto T; Hayashi S; Shibata A; Ogawa S
    Kaku Igaku; 1987 Sep; 24(9):1393-8. PubMed ID: 3437582
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous dipyridamole thallium-201 SPECT imaging methodology, applications, and interpretations.
    Rockett JF; Magill HL; Loveless VS; Murray GL
    Clin Nucl Med; 1990 Oct; 15(10):712-25. PubMed ID: 2225677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Yield of myocardial perfusion study with Thallium 201 in coronary artery disease: planar analysis].
    Dighero H; Canessa J; Lobo G
    Rev Med Chil; 1993 Feb; 121(2):167-9. PubMed ID: 8303113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thallium-201 single-photon emission computed tomography (SPECT) in the assessment of coronary artery disease.
    Verani MS
    Am J Cardiol; 1992 Nov; 70(14):3E-9E. PubMed ID: 1442569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of dipyridamole-induced transient dilation of the left ventricle during thallium-201 scintigraphy in suspected coronary artery disease.
    Chouraqui P; Rodrigues EA; Berman DS; Maddahi J
    Am J Cardiol; 1990 Sep; 66(7):689-94. PubMed ID: 2399884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dipyridamole thallium imaging.
    Beer SG; Heo J; Iskandrian AS
    Am J Cardiol; 1991 May; 67(14):18D-26D. PubMed ID: 2035431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of exercise supplementation on dipyridamole thallium-201 image quality.
    Stern S; Greenberg ID; Corne R
    J Nucl Med; 1991 Aug; 32(8):1559-64. PubMed ID: 1869979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of maximal exercise and dipyridamole thallium-201 planar gated scintigraphy.
    Buell U
    Eur J Nucl Med; 1992; 19(9):826. PubMed ID: 1396879
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined intravenous dipyridamole and symptom-related stress testing.
    Druck MN; Taylor A; Bouchard G; Katz J
    J Nucl Med; 1994 Dec; 35(12):2055. PubMed ID: 7989993
    [No Abstract]   [Full Text] [Related]  

  • 30. Exercise supplementation of dipyridamole for myocardial perfusion imaging.
    DePuey EG
    J Nucl Med; 1991 Aug; 32(8):1564-8. PubMed ID: 1869980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ECG-gated and static technetium-99m-SESTAMIBI planar myocardial perfusion imaging: a comparison with thallium-201 and study of observer variabilities.
    Verzijlbergen JF; Cramer MJ; Niemeyer MG; Ascoop CA; Van der Wall EE; Pauwels EK
    Am J Physiol Imaging; 1990; 5(2):60-7. PubMed ID: 2147553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tomographic myocardial imaging with technetium-99m tetrofosmin. Comparison with tetrofosmin and thallium planar imaging and with angiography.
    Benoit T; Vivegnis D; Lahiri A; Itti R; Braat S; Rigo P
    Eur Heart J; 1996 Apr; 17(4):635-42. PubMed ID: 8733099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advantages of SPECT versus planar technique in nuclear cardiology].
    Bóveda FJ; González A; Azkona MS; Molinero E; Ayerbe P; Iriarte M
    Rev Esp Cardiol; 1994; 47 Suppl 4():124-31. PubMed ID: 7863077
    [No Abstract]   [Full Text] [Related]  

  • 34. Radionuclide exercise testing for coronary artery disease.
    Beller GA
    Cardiol Clin; 1984 Aug; 2(3):367-78. PubMed ID: 6399869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative clinical assessment and dipyridamole thallium-201 scintigraphy for prediction and prevention of cardiac events in patients having major noncardiovascular surgery and known or suspected coronary artery disease.
    Younis L; Stratmann H; Takase B; Byers S; Chaitman BR; Miller DD
    Am J Cardiol; 1994 Aug; 74(4):311-7. PubMed ID: 8059690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dipyridamole thallium scintigraphy and prognosis in coronary artery disease.
    Willerson JT
    J Am Coll Cardiol; 1990 Jan; 15(1):117-8. PubMed ID: 2295719
    [No Abstract]   [Full Text] [Related]  

  • 37. [Usefulness and limitations of stress 201-thallium myocardial imaging in patients with Kawasaki disease].
    Ono Y; Kohata T; Iwatani H; Okuno M; Suzuki A; Kamiya T; Nishimura T; Takamiya M
    J Cardiol; 1991; 21(2):437-44. PubMed ID: 1841930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability of serum drug level following a single oral dose of dipyridamole.
    Segall GM; Davis MJ
    J Nucl Med; 1988 Oct; 29(10):1662-7. PubMed ID: 3171696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved specificity of myocardial thallium-201 single-photon emission computed tomography in patients with left bundle branch block by dipyridamole.
    Burns RJ; Galligan L; Wright LM; Lawand S; Burke RJ; Gladstone PJ
    Am J Cardiol; 1991 Aug; 68(5):504-8. PubMed ID: 1872279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of the severity and extent of reversible perfusion defects during thallium-dipyridamole imaging for cardiac risk assessment before noncardiac surgery.
    Lette J; Waters D; Lapointe J; Gagnon A; Picard M; Cerino M; Kerouac M
    Am J Cardiol; 1989 Aug; 64(5):276-81. PubMed ID: 2756871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.